Litvack Frank bought CAPR

May 13, 2026 · Form 4 insider transaction

Litvack Frank bought 3,937 shares of Capricor Therapeutics, Inc. at $1.39 per share, a transaction worth $5.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.